[Other] Discovery of INCB123667, a potent and selective cyclin-dependent kinase 2 (CDK2) inhibitor for the treatment of cyclin E dysregulated cancers

jyo0112 Post time 2024-4-18 19:13:18 | Show all posts |Read mode
Reward20points

journal£ºEuropean Journal of Cancer

Title: Discovery of INCB123667, a potent and selective cyclin-dependent kinase 2 (CDK2) inhibitor for the treatment of cyclin E dysregulated cancers

Authors£ºS. Wee, M. Ye, Y. Lo, M. Hansbury, N. Shin, M. Weber, V. Roman, L. Huo, H. Skaggs, K. Drake, K. Kapilashrami, K. Stump, J. Yang, S. Chand, C. Timmers, J. Hummel, Y. Ye, G. Zhang, Y.O. Yang, M. Covington, L. Wu, H. Koblish, S. Kim

Published date£º2022-10-27

DOI: 10.1016/S0959-8049(22)01010-3

Article link: https://doi.org/10.1016/S0959-8049(22)01010-3

Article Source£ºElsevier BV¡£


Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
Lady9 Post time 2024-4-18 19:13:19 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report


Junior Member
  • post

  • reply

  • points

    60

Latest Reply



Return to the list